1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

AbbVie Candidate in Pivotal Study – Zacks.com

April 17, 2014Monoclonal Anti-IL-2Rα Receptor Antibodiesadmin

AbbVie Candidate in Pivotal Study
Zacks.com
AbbVie and Biogen are developing daclizumab for relapsing remitting multiple sclerosis (regulatory applications slated for late 2014). AbbVie's Duopa is under review in the U.S. for advanced Parkinson's disease. Meanwhile, veliparib is in another phase ...

and more »

Post navigation

← New Monoclonal Antibodies to Mumps Virus – SelectScience.net (press release) First reported case of tumor hypoglycemia from recurrent renal cell carcinoma – The Oncology Report →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos